The U.S. Supreme Court on Monday asked the federal government to weigh in on whether the high court should hear policyholders' push to revive a proposed class action accusing Anthem Inc. and pharmacy benefit manager Express Scripts Inc. of violating federal benefits law by letting them pay too much for prescription drugs.
The Second Circuit on Monday dismissed an appeal by the plaintiffs in a consolidated class action suit against Anthem Inc. and Express Scripts Inc. that
New Delhi, Oct 21: Biocon Biologics Ltd (BBL) on Thursday said its interchangeable biosimilar Insulin Glargine, under brand name Semglee, would be listed